Richard S. Shames, Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX), sold 657 shares at $8.03 ($5K) on 2019-03-01, disclosed to the SEC on 2019-03-04.
Open-market sale of $5k PTGX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PTGX | SELL | 2017-10-10 | $38K | — | Filing → |
| PTGX | SELL | 2017-09-12 | $106K | — | Filing → |
| PTGX | SELL | 2017-08-30 | $26K | — | Filing → |